Champions Oncology (CSBR) P/E (2011 - 2026)
Champions Oncology (CSBR) P/E from May 2, 2011 to Jul 21, 2026. The TTM Champions Oncology (CSBR) P/E is -36.87. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Champions Oncology (CSBR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -36.87 | -197.66% |
| 2025 | 37.75 | -119.62% |
| 2024 | -192.37 | +1725.67% |
| 2023 | -10.54 | -101.91% |
| 2022 | 552.83 | +97.20% |
| 2021 | 280.34 | -370.06% |
| 2020 | -103.81 | +1.91% |
| 2019 | -101.86 | -103.30% |
| 2018 | 3.09K | -33400.90% |
| 2017 | -9.28 | +208.91% |
| 2016 | -3.00 | +31.16% |
| 2015 | -2.29 | -35.05% |
| 2014 | -3.53 | -37.60% |
| 2013 | -5.65 | +313.51% |
| 2012 | -1.37 | -61.86% |
| 2011 | -3.58 | N/A |
Comparison Champions Oncology (CSBR) P/E with competitors
Champions Oncology (CSBR) P/E is -36.87.